Treatment with anti-cancer drug T-DM1 after pertuzumab is 'good option'
Patients with HER2-positive breast cancer, whose disease has progressed after being treated initially with pertuzumab in combination with trastuzumab and a taxane, can respond well to treatment with T-DM1—a drug that combines ...
Nov 15, 2019
0
2